ArticleBritish journal of cancer2010

Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progression.

J Hao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.